Pesticide exposure and risk of Alzheimer's disease: A systematic review and meta-analysis

Scientific Reports

Volumn 6, Issue , 2016, Pages

  Yan, Dandan ^a   Zhang, Yunjian ^a   Liu, Liegang ^a   Yan, Hong ^a  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

PESTICIDE;

ALZHEIMER DISEASE; ENVIRONMENTAL EXPOSURE; HUMAN; META ANALYSIS; OCCUPATIONAL EXPOSURE; ODDS RATIO; RISK FACTOR;

ALZHEIMER DISEASE; ENVIRONMENTAL EXPOSURE; HUMANS; OCCUPATIONAL EXPOSURE; ODDS RATIO; PESTICIDES; RISK FACTORS;

EID: 84984906808     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep32222     Document Type: Article

References (44)

1. Nussbaum, R. L. & Ellis, C. E. Alzheimer's disease and Parkinson's disease. The New England journal of medicine 348, 1356-1364, doi: 10.1056/NEJM2003ra020003 (2003).
2. Ringman, J. M. et al. Early behavioural changes in familial Alzheimer's disease in the Dominantly Inherited Alzheimer Network. Brain: a journal of neurology 138, 1036-1045, doi: 10.1093/brain/awv004 (2015).
3. Apostolova, L. G. et al. Brain amyloidosis ascertainment from cognitive, imaging, and peripheral blood protein measures. Neurology 84, 729-737, doi: 10.1212/wnl.0000000000001231 (2015).
4. Wang, L. et al. Spatially distinct atrophy is linked to beta-amyloid and tau in preclinical Alzheimer disease. Neurology 84, 1254-1260, doi: 10.1212/wnl.0000000000001401 (2015).
5. Yaffe, K., Haan, M., Byers, A., Tangen, C. & Kuller, L. Estrogen use, APOE, and cognitive decline: evidence of gene-environment interaction. Neurology 54, 1949-1954 (2000).
6. Luck, T. et al. Apolipoprotein E epsilon 4 genotype and a physically active lifestyle in late life: analysis of gene-environment interaction for the risk of dementia and Alzheimer's disease dementia. Psychological medicine 44, 1319-1329, doi: 10.1017/s0033291713001918 (2014).
7. Tsuboi, Y., Josephs, K. A., Cookson, N. & Dickson, D. W. APOE E4 is a determinant for Alzheimer type pathology in progressive supranuclear palsy. Neurology 60, 240-245 (2003).
8. Ryman, D. C. et al. Symptom onset in autosomal dominant Alzheimer disease: a systematic review and meta-analysis. Neurology 83, 253-260, doi: 10.1212/wnl.0000000000000596 (2014).
9. Jean, H. et al. Alzheimer's disease: preliminary study of spatial distribution at birth place. Social science & medicine (1982) 42, 871-878 (1996).
10. Ullrich, C. & Humpel, C. Rotenone induces cell death of cholinergic neurons in an organotypic co-culture brain slice model. Neurochemical research 34, 2147-2153, doi: 10.1007/s11064-009-0014-9 (2009).
11. Tartaglione, A. M., Venerosi, A. & Calamandrei, G. Early-Life Toxic Insults and Onset of Sporadic Neurodegenerative Diseases-an Overview of Experimental Studies. Current topics in behavioral neurosciences, doi: 10.1007/7854-2015-416 (2015).
12. Hayden, K. M. et al. Occupational exposure to pesticides increases the risk of incident AD: the Cache County study. Neurology 74, 1524-1530, doi: 10.1212/WNL.0b013e3181dd4423 (2010).
13. Parron, T., Requena, M., Hernandez, A. F. & Alarcon, R. Association between environmental exposure to pesticides and neurodegenerative diseases. Toxicol Appl Pharmacol 256, 379-385, doi: 10.1016/j.taap.2011.05.006 (2011).
14. Baltazar, M. T. et al. Pesticides exposure as etiological factors of Parkinson's disease and other neurodegenerative diseases-a mechanistic approach. Toxicology letters 230, 85-103, doi: 10.1016/j.toxlet.2014.01.039 (2014).
15. Kamel, F. & Hoppin, J. A. Association of pesticide exposure with neurologic dysfunction and disease. Environmental health perspectives 112, 950-958 (2004).
16. Osteen, C. D. & Fernandez-Cornejo, J. Economic and policy issues of US agricultural pesticide use trends. Pest management science 69, 1001-1025, doi: 10.1002/ps.3529 (2013).
17. Tyas, S. L., Manfreda, J., Strain, L. A. & Montgomery, P. R. Risk factors for Alzheimer's disease: a population-based, longitudinal study in Manitoba, Canada. International journal of epidemiology 30, 590-597 (2001).
18. Baldi, I. et al. Neurodegenerative diseases and exposure to pesticides in the elderly. American journal of epidemiology 157, 409-414 (2003).
19. Gun, R. T. et al. Occupational risk factors for Alzheimer disease: a case-control study. Alzheimer disease and associated disorders 11, 21-27 (1997).
20. The Canadian Study of Health and Aging: risk factors for Alzheimer's disease in Canada. Neurology 44, 2073-2080 (1994).
21. Gauthier, E. et al. Environmental pesticide exposure as a risk factor for Alzheimer's disease: a case-control study. Environmental research 86, 37-45, doi: 10.1006/enrs.2001.4254 (2001).
22. French, L. R. et al. A case-control study of dementia of the Alzheimer type. American journal of epidemiology 121, 414-421 (1985).
23. Zaganas, I. et al. Linking pesticide exposure and dementia: what is the evidence? Toxicology 307, 3-11, doi: 10.1016/j.tox.2013.02.002 (2013).
24. Bosma, H., van Boxtel, M. P., Ponds, R. W., Houx, P. J. & Jolles, J. Pesticide exposure and risk of mild cognitive dysfunction. Lancet (London, England) 356, 912-913 (2000).
25. Baldi, I. et al. Neurobehavioral effects of long-term exposure to pesticides: results from the 4-year follow-up of the PHYTONER study. Occupational and environmental medicine 68, 108-115, doi: 10.1136/oem.2009.047811 (2011).
26. Lindsay, J., Hebert, R. & Rockwood, K. The Canadian Study of Health and Aging: risk factors for vascular dementia. Stroke; a journal of cerebral circulation 28, 526-530 (1997).
27. Hebert, R. et al. Vascular dementia: incidence and risk factors in the Canadian study of health and aging. Stroke; a journal of cerebral circulation 31, 1487-1493 (2000).
28. Li, G. et al. Common Pesticide, Dichlorodiphenyltrichloroethane (DDT), Increases Amyloid-beta Levels by Impairing the Function of ABCA1 and IDE: Implication for Alzheimer's Disease. Journal of Alzheimer's disease: JAD, doi: 10.3233/jad-150024 (2015).
29. Richardson, J. R. et al. Elevated serum pesticide levels and risk for Alzheimer disease. JAMA neurology 71, 284-290, doi: 10.1001/jamaneurol.2013.6030 (2014).
30. Salazar, J. G. et al. Amyloid beta peptide levels increase in brain of AbetaPP Swedish mice after exposure to chlorpyrifos. Current Alzheimer research 8, 732-740 (2011).
31. Singh, N. K., Banerjee, B. D., Bala, K., Basu, M. & Chhillar, N. Polymorphism in Cytochrome P450 2D6, Glutathione S-Transferases Pi 1 Genes, and Organochlorine Pesticides in Alzheimer Disease: A Case-Control Study in North Indian Population. Journal of geriatric psychiatry and neurology 27, 119-127, doi: 10.1177/0891988714522698 (2014).
32. Xu, W. et al. Education and Risk of Dementia: Dose-Response Meta-Analysis of Prospective Cohort Studies. Molecular neurobiology, doi: 10.1007/s12035-015-9211-5 (2015).
33. de Oliveira, F. F., Bertolucci, P. H., Chen, E. S. & Smith, M. C. Risk factors for age at onset of dementia due to Alzheimer's disease in a sample of patients with low mean schooling from Sao Paulo, Brazil. International journal of geriatric psychiatry 29, 1033-1039, doi: 10.1002/gps.4094 (2014).
34. Higgins, J. P., Thompson, S. G., Deeks, J. J. & Altman, D. G. Measuring inconsistency in meta-analyses. BMJ (Clinical research ed.) 327, 557-560, doi: 10.1136/bmj.327.7414.557 (2003).
35. McKhann, G. et al. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 34, 939-944 (1984).
36. Moher, D., Liberati, A., Tetzlaff, J. & Altman, D. G. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA Statement. Open medicine: a peer-reviewed, independent, open-access journal 3, e123-e130 (2009).
37. Stroup, D. F. et al. Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group. Jama 283, 2008-2012 (2000).
38. Stang, A. Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in metaanalyses. European journal of epidemiology 25, 603-605, doi: 10.1007/s10654-010-9491-z (2010).
39. Greenland, S. Quantitative methods in the review of epidemiologic literature. Epidemiologic reviews 9, 1-30 (1987).
40. Hardy, R. J. & Thompson, S. G. Detecting and describing heterogeneity in meta-analysis. Statistics in medicine 17, 841-856 (1998).
41. Higgins, J. P. Commentary: Heterogeneity in meta-analysis should be expected and appropriately quantified. International journal of epidemiology 37, 1158-1160, doi: 10.1093/ije/dyn204 (2008).
42. Doi, S. A. & Thalib, L. A quality-effects model for meta-analysis. Epidemiology (Cambridge, Mass) 19, 94-100, doi: 10.1097/EDE.0b013e31815c24e7 (2008).
43. Egger, M., Davey Smith, G., Schneider, M. & Minder, C. Bias in meta-analysis detected by a simple, graphical test. BMJ (Clinical research ed.) 315, 629-634 (1997).
44. Begg, C. B. & Mazumdar, M. Operating characteristics of a rank correlation test for publication bias. Biometrics 50, 1088-1101 (1994).